You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KPTI Sale Disclosure
Abate Kristin · SEC Form 4 · Filed Sep 2, 2026
Sale
Calculated transaction value
$38.38
Abate Kristin Chief Accounting Officer
KPTI
Transaction date
Sep 1, 2026
Public filing date
Sep 2, 2026
Filing lag
Filed 1 day later
KPTI daily price context
Close on/before transaction
$1.85
Sep 1, 2026
First close after public filing
$1.77
Sep 3, 2026
30-day return after filing
-54.68%
Through Oct 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 19 shares @ $2.02
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-380404
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$38.38
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Karyopharm Therapeutics Inc. KPTI Current | Sale | Sep 1, 2026 | $38.38 |